PRNP and cancer: The essential hypothesis is that, morphologically, exosomes originating from cancer cells are considered to be reservoirs of cancer biomarkers [62], while exosomes containing the prion protein, β-amyloid (Aβ), and α-synuclein, as neurodegenerative disease-associated proteins, are considered markers for those medical conditions [83].